Skip to main content
Equibles

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

Bank

Position in ABT — Abbott Laboratories

CIK 1694217 FRANKFURT AM MAIN, 2M
Back to ABT Full portfolio

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,586,773
-$1,920,834 QoQ
Shares Held
392,184
+7.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#260
of 2,959 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 16% Shared 0% None 84%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Dec 31, 2025
CallValue
$22,051,040
CallShares
176,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $2,252,750,197 across 12 Medical Devices names. ABT ranks #6 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 13,002,965 $1,176,248,212
2 MDT
Medtronic plc
 5,534,109 $432,933,344
3 BSX
Boston Scientific Corp
 9,227,707 $393,838,533
4 SYK
Stryker Corp
 495,342 $155,953,472
5 DXCM
Dexcom Inc
 713,933 $48,083,385
6 ABT
Abbott Laboratories
This page 		392,184 $35,586,773
7 TMDX
TransMedics Group, Inc.
 75,090 $4,987,477
8 STE
STERIS plc
 12,689 $2,671,922

All Filings in ABT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,586,773 392,184
2026-03-31 $37,507,607 365,322
2025-12-31 $48,294,783 385,464
2025-12-31 $22,051,040 176,000
2025-09-30 $410,768,797 3,066,812
2025-09-30 $23,573,440 176,000
2025-06-30 $622,616,511 4,577,726
2025-06-30 $20,129,480 148,000
2025-03-31 $637,097,519 4,802,846
2025-03-31 $19,632,200 148,000
2024-12-31 $109,921,991 971,815
2024-12-31 $16,853,390 149,000
2024-09-30 $21,832,915 191,500
2024-09-30 $110,269,215 967,189
2024-06-30 $20,002,675 192,500
2024-06-30 $731,320,551 7,038,019
2024-03-31 $21,879,550 192,500
2024-03-31 $813,393,693 7,156,376
2023-12-31 $40,065,480 364,000
2023-12-31 $353,858,536 3,214,850
2023-09-30 $69,526,385 717,877
2023-09-30 $35,253,400 364,000
2023-06-30 $39,792,300 365,000
2023-06-30 $40,889,802 375,067
2023-03-31 $36,757,380 363,000
2023-03-31 $36,857,525 363,989
2022-12-31 $43,806,210 399,000
2022-12-31 $52,741,027 480,381
2022-09-30 $419,867,569 4,339,268
2022-09-30 $66,232,220 684,500
2022-06-30 $76,000,675 699,500
2022-06-30 $580,079,957 5,338,978
2022-03-31 $81,609,220 689,500
2022-03-31 $111,279,228 940,176
2021-12-31 $80,292,170 570,500
2021-12-31 $652,469,371 4,635,991
2021-09-30 $657,804,067 5,568,476
2021-09-30 $66,920,645 566,500
2021-06-30 $65,674,345 566,500
2021-06-30 $254,649,169 2,196,577
2021-03-31 $67,889,360 566,500
2021-03-31 $392,198,927 3,272,688
2020-12-31 $449,425,241 4,104,715
2020-12-31 $48,339,835 441,500
2020-09-30 $368,802,122 3,388,791
2020-09-30 $32,757,830 301,000
2020-06-30 $8,987,569 98,300
2020-06-30 $46,642,097 510,140
2020-03-31 $39,436,137 499,761
2020-03-31 $6,573,203 83,300

Report a Problem

Category
Description
Email (optional, for follow-up)